Basepoint Wealth’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Basepoint Wealth's ELV Position: Q2 2026 in Review
Basepoint Wealth increased its Elevance Health (ELV) stake by 0.88% in Q2 2026, buying an estimated $2.6K and bringing the position to 803 shares worth $311K. The position accounts for 0.18% of the portfolio, ranked #80.
Basepoint Wealth first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $914K in Q4 2021. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Basepoint Wealth held 803 shares of Elevance Health worth $311K as of Q2 2026.
- Basepoint Wealth bought 7 Elevance Health shares in Q2 2026, an estimated $2.6K.
- Elevance Health made up 0.18% of Basepoint Wealth's portfolio in Q2 2026, its #80 holding.
- Basepoint Wealth first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
- Basepoint Wealth's Elevance Health position peaked at $914K in Q4 2021.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Basepoint Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.